ETS domain-containing protein Elk-4, also known as Serum response factor accessory protein 1 (SRF accessory protein 1) or ELK4, is a member of the ETS transcription factor family. It is involved in the regulation of gene expression by forming a ternary complex with serum response factor (SRF) and binding to serum response elements (SRE) in the promoters of target genes. Elk-4 is implicated in the control of cell growth and differentiation, and is activated by various signal transduction pathways, primarily through phosphorylation by MAPK signaling. The chemical class designated as ETS domain-containing protein Elk-4 Activators comprises a specialized group of compounds designed to modulate cellular processes through the activation of the ETS domain-containing transcription factor Elk-4. Elk-4 is a key regulator of gene expression, involved in the control of diverse cellular functions such as cell proliferation, differentiation, and response to extracellular signals.
The activation of Elk-4 by these compounds involves specific molecular interactions, where activators engage with the transcription factor, inducing conformational changes that enhance its binding to target DNA sequences and subsequent transcriptional activity. The methods employed by Elk-4 Activators are intricately linked to their structural features. These activators typically possess specific chemical motifs that enable selective binding to Elk-4, promoting a targeted and efficient response. The specificity of this interaction is crucial for the precise modulation of Elk-4's transcriptional activity. Advanced structural techniques, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, can be employed to unravel the details of the binding sites and conformational alterations induced by Elk-4 Activators.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is known to activate protein kinase C (PKC), which can lead to the activation of MAPK pathways. This, in turn, could result in the phosphorylation and activation of Elk-4, promoting its transcriptional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can lead to the activation of PKA. PKA can modulate various proteins in the MAPK pathway, potentially influencing Elk-4 activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate MAPK pathways as a stress response, which could lead to the activation of Elk-4. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
As an omega-3 fatty acid, EPA can modulate cellular signaling and has been reported to activate MAPK, which may indirectly activate Elk-4. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
As a precursor for eicosanoids, arachidonic acid can modulate various signaling pathways, potentially affecting MAPK and Elk-4 activity. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide can activate protein kinase C, which can engage MAPK pathways and potentially influence Elk-4 phosphorylation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This sphingolipid metabolite can activate G protein-coupled receptors, leading to MAPK activation and subsequent Elk-4 activity. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As a reactive oxygen species, H2O2 can serve as a secondary messenger in cell signaling, potentially activating MAPK and influencing Elk-4. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can impact several signaling pathways, including those involving GSK3β, which could result in changes to MAPK-mediated Elk-4 activation. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Thrombin, through protease-activated receptors, can initiate signaling leading to MAPK activation and potentially increase Elk-4 activity. | ||||||